Frag' FlorenceEvidenz. Klar. Anwendbar.
Uhr 7/8Sources Journal Tree
Easy Demo

Lokaler Crossref-Datenbestand · journal-article

Exploring the Role of HSD17B2 in Colorectal Cancer Through Bioinformatic Analysis: Preliminary Insights for Prognostic Evaluation

Ana Belen Diaz-Ruano, Eliana Gomez-Jimenez, Alba Hidalgo-Ramirez, Giselle Xavier-Reis, Nieves Casillas-Ruiz, Noelia Garcia-Mascaraque, Alfonso Rubio-Navarro, Maria Paz Zafra, Juan Antonio Marchal, Manuel Picon-Ruiz

International Journal of Molecular Sciences · 2026

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second leading cause of cancer-related mortality worldwide. Although screening has reduced CRC in older adults, cases in younger individuals are rising, highlighting the need for early biomarkers. Emerging research highlights the role of estrogen metabolism in CRC progression, with enzymes such as hydroxysteroid (17-beta) dehydrogenase (HSD17B) being increasingly implicated. In this study, we performed a bioinformatics analysis using publicly available datasets, including The Cancer Genome Atlas Colon Adenocarcinoma (TCGA-COAD) cohort and two independent Gene Expression Omnibus (GEO) cohorts (GSE40967 and GSE41258), to investigate the role of HSD17B enzymes in CRC. Our results suggest that HSD17B2 is frequently downregulated in precancerous lesions and early-stage CRC, which may contribute to elevated estradiol levels and a tumor-promoting microenvironment. In advanced stages, higher HSD17B2 expression levels are associated with poorer survival outcomes in retrospective cohorts. Other HSD17B enzymes also exhibit significant expression changes, further complicating the hormonal landscape of CRC. In addition, estrone, traditionally considered a weaker estrogen, emerges as a potential driver of CRC progression. Our in-silico analyses indicate that HSD17B2 and HSD17B11 warrant further investigation as candidate biomarkers for distinguishing CRC from benign and precancerous conditions, with the combination showing strong discriminatory power in Receiver Operating Characteristic (ROC) analyses. Overall, these findings highlight the potential role of estrogen metabolism in CRC and suggest that HSD17B enzymes may hold value as candidate prognostic and diagnostic indicators, though their clinical utility remains hypothetical at this stage. Experimental and clinical validation is strictly required to confirm these in silico observations and to clarify their mechanisms in CRC.

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Ana Belen Diaz-Ruano, Eliana Gomez-Jimenez, Alba Hidalgo-Ramirez, Giselle Xavier-Reis, Nieves Casillas-Ruiz, Noelia Garcia-Mascaraque, Alfonso Rubio-Navarro, Maria Paz Zafra, Juan Antonio Marchal, Manuel Picon-Ruiz
Quelle
International Journal of Molecular Sciences
Publikation
2026-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
1422-0067
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

Ana Belen Diaz-Ruano, Eliana Gomez-Jimenez, Alba Hidalgo-Ramirez, Giselle Xavier-Reis, Nieves Casillas-Ruiz, Noelia Garcia-Mascaraque, Alfonso Rubio-Navarro, Maria Paz Zafra, Juan Antonio Marchal, Manuel Picon-Ruiz (2026). Exploring the Role of HSD17B2 in Colorectal Cancer Through Bioinformatic Analysis: Preliminary Insights for Prognostic Evaluation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177614
RIS BibTeX CSL-JSON

Kontext

Themen, Förderung und Nutzung

Lizenzhinweise: Lizenz 1